pubmed-article:14655041 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14655041 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:14655041 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:14655041 | lifeskim:mentions | umls-concept:C0042963 | lld:lifeskim |
pubmed-article:14655041 | lifeskim:mentions | umls-concept:C0011777 | lld:lifeskim |
pubmed-article:14655041 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
pubmed-article:14655041 | lifeskim:mentions | umls-concept:C0526950 | lld:lifeskim |
pubmed-article:14655041 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:14655041 | pubmed:dateCreated | 2004-1-9 | lld:pubmed |
pubmed-article:14655041 | pubmed:abstractText | To establish whether the combination of a corticosteroid (dexamethasone) and the newer serotonin-3 (5-HT(3)) receptor antagonist ramosetron is superior to ramosetron alone in controlling cisplatin-induced emesis. | lld:pubmed |
pubmed-article:14655041 | pubmed:language | eng | lld:pubmed |
pubmed-article:14655041 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14655041 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14655041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14655041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14655041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14655041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14655041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14655041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14655041 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14655041 | pubmed:month | Jan | lld:pubmed |
pubmed-article:14655041 | pubmed:issn | 0941-4355 | lld:pubmed |
pubmed-article:14655041 | pubmed:author | pubmed-author:VillalonAnton... | lld:pubmed |
pubmed-article:14655041 | pubmed:author | pubmed-author:ChanValorieV | lld:pubmed |
pubmed-article:14655041 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14655041 | pubmed:volume | 12 | lld:pubmed |
pubmed-article:14655041 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14655041 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14655041 | pubmed:pagination | 58-63 | lld:pubmed |
pubmed-article:14655041 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:meshHeading | pubmed-meshheading:14655041... | lld:pubmed |
pubmed-article:14655041 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:14655041 | pubmed:articleTitle | Multicenter, randomized trial of ramosetron plus dexamethasone versus ramosetron alone in controlling cisplatin-induced emesis. | lld:pubmed |
pubmed-article:14655041 | pubmed:affiliation | Manila Doctors Hospital, T.M. Kalaw Street, Manila, Philippines. ahvillalon@yahoo.com | lld:pubmed |
pubmed-article:14655041 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14655041 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:14655041 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:14655041 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:14655041 | pubmed:publicationType | Multicenter Study | lld:pubmed |